Short communication Characterization of a recurrent t(1;2)(p36;p24) in human uterine leiomyoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Monitoring ligand modulation of protein-protein interactions by mass spectrometry: estrogen receptor alpha-SRC1.

  2008cited by this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma.

  2005cited by this paper
• Clinical Response, Vascular Change, and Angiogenesis in Gonadotropin-Releasing Hormone Analogue-Treated Women with Uterine Myomas

  2005cited by this paper
• Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix

  2005cited by this paper
• Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review.

  2005cited by this paper
• Uterine Leiomyomata with t(10;17) Disrupt the Histone Acetyltransferase MORF

  2004cited by this paper
• Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids

  2004cited by this paper
• Pathogenesis of axonal dystrophy and demyelination in αA‐crystallin‐expressing transgenic mice

  2003cited by this paper
• Microarray analysis in fibroids: which gene list is the correct list?

  2003cited by this paper
• Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium.

  2003cited by this paper
• PEP-19 overexpression in human uterine leiomyoma.

  2003cited by this paper
• Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.

  2003cited by this paper
• Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata.

  2003cited by this paper
• Tumor suppressor pRB functions as a co‐repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription

  2003cited by this paper
• Etiology and pathogenesis of uterine leiomyomas: a review.

  2003cited by this paper
• Gene Expression Profile of Leiomyoma and Myometrium and the Effect of Gonadotropin Releasing Hormone Analogue Therapy

  2003cited by this paper
• Insights from gene arrays on the development and growth regulation of uterine leiomyomata.

  2002cited by this paper
• Molecular Mechanisms and Cellular Biology of the Steroid Receptor Coactivator (SRC) Family in Steroid Receptor Function

  2002cited by this paper
• The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle.

  2001cited by this paper
• Growth Factors Signal to Steroid Receptors through Mitogen-activated Protein Kinase Regulation of p160 Coactivator Activity*

  2001cited by this paper
• Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.

  2001cited by this paper
• Intersectin, an adaptor protein involved in clathrin-mediated endocytosis, activates mitogenic signaling pathways.

  2000cited by this paper
• AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor

  2000cited by this paper
• Fibroids, infertility and pregnancy wastage.

  2000cited by this paper
• Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP.

  2000cited by this paper
• HMGI-C and HMGI(Y) Immunoreactivity Correlates with Cytogenetic Abnormalities in Lipomas, Pulmonary Chondroid Hamartomas, Endometrial Polyps, and Uterine Leiomyomas and is Compatible with Rearrangement of the HMGI-C and HMGI(Y) Genes

  2000cited by this paper
• Primer3 on the WWW for general users and for biologist programmers.

  2000cited by this paper
• Deletion 7q in uterine leiomyoma: fluorescence in situ hybridization characterization on primary cytogenetic preparations.

  1999cited by this paper
• Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment.

  1999cited by this paper
• Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas.

  1999cited by this paper
• The mammalian Cut homeodomain protein functions as a cell‐cycle‐dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase

  1998cited by this paper
• The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata.

  1997cited by this paper
• Steroid receptor coactivator-1 is a histone acetyltransferase

  1997cited by this paper
• Two discrete regions of deletion at 7q in uterine leiomyomas

  1997cited by this paper
• Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas

  1997cited by this paper
• PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line

  1996cited by this paper
• MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

  1995cited by this paper
• Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours

  1995cited by this paper
• Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains.

  1995cited by this paper
• Amplification of chromosome subregion 12p11.2-p12.1 in a metastasis of an i(12p)-negative seminoma: relationship to tumor progression?

  1994cited by this paper
• Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas

  1994cited by this paper
• Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist * †

  1993cited by this paper
• Deletion 7q22 in uterine leiomyoma. A cytogenetic review.

  1993cited by this paper
• The frequency of uterine leiomyomas.

  1990cited by this paper
• Is the chromosome band 1p36 another hot‐spot for rearrangements in uterine leiomyoma?

  1990cited by this paper
• Uterine fibroids: A clinical review

  1990cited by this paper
• Cytogenetical observations in human benign uterine leiomyomas.

  1988cited by this paper
• Expression of human myeloid-associated surface antigens in human-mouse myeloid cell hybrids.

  1983cited by this paper

• AJAP1 affects behavioral changes and GABABR1 level in epileptic mice.

  2020cites this paper
• Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri

  2019cites this paper
• Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas

  2018cites this paper
• MED12 mutations and metabolomic changes in uterine leiomyomas

  2017cites this paper
• Molecular and clinical attributes of uterine leiomyomas

  2017cites this paper
• Molecular classification of uterine leiomyomas by genome-wide methods

  2016cites this paper
• Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers

  2016cites this paper
• Reprint of "Steroid receptor coactivators as therapeutic targets in the female reproductive system".

  2015cites this paper
• Steroid receptor coactivators as therapeutic targets in the female reproductive system.

  2015cites this paper
• Genomics of uterine leiomyomas: insights from high-throughput sequencing.

  2014cites this paper
• Uterine fibroids : response to novel treatment modalities

  2013cites this paper
• The role of the alcohol dehydrogenase-1 (ADH1) gene in the pathomechanism of uterine leiomyoma.

  2013cites this paper
• Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma

  2013cites this paper
• Występowanie leiomyoma cellulare w materiale pooperacyjnym - opis sytuacji klinicznych

  2013cites this paper
• Leiomyoma cellulare in postoperative material: clinical cases

  2013cites this paper
• MicroRNAs and their role in gynecological tumors

  2011cites this paper